AAPL $349.51 +5.82% ▲ ACN $264.27 +4.42% ▲ ADBE $248.48 +1.82% ▲ ADEA $16.92 -5.26% ▼ ADIG $18.91 +2.55% ▲ ADP $303.54 +2.54% ▲ ADSK $270.09 +7.04% ▲ AEHR $60.84 -8.30% ▼ AEVA $9.49 +4.06% ▲ AGYS $122.64 +2.31% ▲ AI $11.96 +3.50% ▲ AIP $18.10 -4.28% ▼ ALAB $223.27 -2.33% ▼ ALKT $13.26 -1.49% ▼ ALNT $79.56 -9.74% ▼ AMBA $60.92 -3.30% ▼ AMBQ $41.54 -7.03% ▼ AMD $488.78 -5.17% ▼ AMPL $17.19 +2.08% ▲ AMZN $266.03 +6.50% ▲ ANET $178.48 -5.34% ▼ AOSL $21.17 -5.66% ▼ APLD $16.61 -6.89% ▼ APP $271.75 +10.69% ▲ APPN $49.82 +1.47% ▲ APPS $9.54 +2.36% ▲ ARM $191.80 -7.79% ▼ ARRY $5.33 +15.12% ▲ ARW $202.63 -2.94% ▼ ASML $1,496.30 -4.08% ▼ AAPL $349.51 +5.82% ▲ ACN $264.27 +4.42% ▲ ADBE $248.48 +1.82% ▲ ADEA $16.92 -5.26% ▼ ADIG $18.91 +2.55% ▲ ADP $303.54 +2.54% ▲ ADSK $270.09 +7.04% ▲ AEHR $60.84 -8.30% ▼ AEVA $9.49 +4.06% ▲ AGYS $122.64 +2.31% ▲ AI $11.96 +3.50% ▲ AIP $18.10 -4.28% ▼ ALAB $223.27 -2.33% ▼ ALKT $13.26 -1.49% ▼ ALNT $79.56 -9.74% ▼ AMBA $60.92 -3.30% ▼ AMBQ $41.54 -7.03% ▼ AMD $488.78 -5.17% ▼ AMPL $17.19 +2.08% ▲ AMZN $266.03 +6.50% ▲ ANET $178.48 -5.34% ▼ AOSL $21.17 -5.66% ▼ APLD $16.61 -6.89% ▼ APP $271.75 +10.69% ▲ APPN $49.82 +1.47% ▲ APPS $9.54 +2.36% ▲ ARM $191.80 -7.79% ▼ ARRY $5.33 +15.12% ▲ ARW $202.63 -2.94% ▼ ASML $1,496.30 -4.08% ▼
Other NMS

Acumen Pharmaceuticals, Inc. (ABOS)

Other · Healthcare · Biotechnology

ABOS
0.22-0.02 -7.72%Past year
Loading chart…
Loading financials…

Company snapshot

Ticker
ABOS
Exchange
NMS
Sector
Healthcare
Industry
Biotechnology
Market cap
$15.64M
Employees
60
Currency
USD
Website
https://acumenpharm.com

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a…

Related Other stocks

Quotes & data — follow Acumen Pharmaceuticals, Inc. (ABOS) across major market-data sources